Lantheus Medical Imaging, Inc.
331 Treble Cove Road
North Billerica
Massachusetts
01862
United States
Tel: 800-299-3431
Website: http://www.lantheus.com/
Email: bi.webadmin@lantheus.com
About Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, including the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures. The Company is headquartered in North Billerica, Massachusetts with offices in Puerto Rico and Canada. For more information, visit www.lantheus.com.
Stock Exchange: NASDAQ
Stock Symbol: LNTH
153 articles about Lantheus Medical Imaging, Inc.
-
EPIX Pharmaceuticals, Inc. Announces Sale of U.S., Canadian and Australian Rights for MS-325 to Lantheus Medical Imaging for $28 Million
4/7/2009
-
New Lantheus Medical Imaging Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography
3/30/2009
-
Lantheus Medical Imaging to Present New Cardiac Imaging Data at the American College of Cardiology 58th Annual Scientific Sessions in Orlando
3/25/2009
-
Lantheus Medical Imaging Release: New Study Published in Journal of the American College of Cardiology Finds Utilization of Contrast Echocardiography with DEFINITY(R) Improves Patient Diagnosis and Management
2/24/2009
-
Lantheus Medical Imaging Release: New Study Published in the Journal of Nuclear Cardiology Explores the Utility of SPECT Myocardial Perfusion Imaging with Cardiolite(R) in Patients with New-Onset of Heart Failure
1/27/2009
-
Artery Highlighter Could Reveal Heart Attack Risk, Lantheus Medical Imaging Study
1/12/2009
-
Lantheus Medical Imaging Welcomes New ASE Consensus Statement on Clinical Applications of Contrast Echocardiography
11/6/2008
-
Lantheus Medical Imaging Selects QUMAS as Their Regulatory Partner of Choice Across the Enterprise
9/24/2008
-
Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into Agreement to Co-Promote Bracco’s CardioGen-82® (Rubidium Rb 82 Generator)
9/23/2008
-
Lantheus Medical Imaging Presents Phase I Study Results of Novel PET Myocardial Perfusion Imaging Tracer
6/17/2008
-
Lantheus Medical Imaging Presents Phase I Study Results of Novel PET Myocardial Perfusion Imaging Tracer
6/17/2008
-
Lantheus Medical Imaging Receives Performance Award from Premier Purchasing Partners, L.P.
6/12/2008
-
Lantheus Medical Imaging Initiates CaRES Registry to Further Evaluate DEFINITY(R) in Patients with Suboptimal Echocardiograms
5/7/2008